Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.

Objective: To determine the safety and efficacy of PRC-063, a once-daily, multilayer, extended-release (ER) formulation of methylphenidate (MPH) hydrochloride, in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children in a randomized, double-blind, parallel group, dose-optimize...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Child & Adolescent Psychopharmacology Vol. 30; no. 10; pp. 580 - 590
Autores principales: Childress, Ann C., Brams, Matthew N., Cutler, Andrew J., Donnelly, Graeme A.E., Bhaskar, Sailaja
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Mary Ann Liebert, Inc. Dec2020
Acceso en línea:Ver este registro en EBSCOhost